CAMT Camtek Ltd.
QT21| Index | — | P/E | 177.46 | EPS (ttm) | 0.61 | Insider Own | 0.28% | Shs Outstand | 46.67M | Perf Week | -12.21% |
| Market Cap | 5.05B | Forward P/E | 21.35 | EPS next Y | 5.07 | Insider Trans | -23.40% | Shs Float | 28.24M | Perf Month | -34.47% |
| Enterprise Value | 4.91B | PEG | 7.51 | EPS next Q | 0.99 | Short Float | 11.84% | Perf Quarter | -28.60% | ||
| Income | 38.00M | P/S | 9.93 | EPS this Y | 13.22% | Short Ratio | 7.07 | Perf Half Y | -40.75% | ||
| Sales | 509.00M | P/B | 7.12 | EPS next Y | 39.88% | ROA | 2.81% | Short Interest | 3.34M | Perf YTD | 1.79% |
| Book/sh | 15.21 | P/C | 8.02 | EPS next 5Y | 23.63% | ROE | 5.82% | 52W High | 215.99 -49.88% | Perf Year | -12.72% |
| Cash/sh | 13.50 | P/FCF | — | EPS past 3/5Y | -14.43% 14.01% | ROIC | 7.81% | 52W Low | 91.91 17.78% | Perf 3Y | 113.05% |
| Dividend Est. | — | EV/EBITDA | 169.30 | Sales past 3/5Y | 15.61% 26.03% | Gross Margin | 50.05% | Volatility | 4.96% 5.37% | Perf 5Y | 170.02% |
| Dividend TTM | — | EV/Sales | 9.65 | EPS Y/Y TTM | -77.57% | Oper. Margin | 23.19% | ATR (14) | 8.37 | Perf 10Y | 3403.24% |
| Dividend Ex-Date | Apr 03, 2024 | Quick Ratio | 6.58 | Sales Y/Y TTM | 8.07% | Profit Margin | 7.40% | RSI (14) | 29.46 | Recom | 2.31 |
| Dividend Gr. 3/5Y | — 50.90% | Current Ratio | 7.38 | EPS Q/Q | -1.27% | SMA20 | -18.62% | Beta | 1.71 | Target Price | 175.00 |
| Payout | 0.00% | Debt/Eq | 0.69 | Sales Q/Q | 8.13% | SMA50 | -22.81% | Rel Volume | 2.09 | Prev Close | 116.68 |
| Employees | 709 | LT Debt/Eq | 0.69 | Earnings | Nov 04 | SMA200 | -31.20% | Avg Volume | 466.12K | Price | 108.25 |
| IPO Date | Jul 28, 2000 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.45% 2.15% | Net Debt/EBITDA | -4.90 | Volume | 972,994 | Change | -7.22% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Nov-02-26 | Downgrade | Morgan Stanley | Equal Weight → Underweight | $152 → $126 |
| Sep-28-26 | Reiterated | Morgan Stanley | Equal Weight | $165 → $152 |
| Sep-22-26 | Reiterated | Cantor Fitzgerald | Neutral | $120 → $175 |
| Aug-11-26 | Reiterated | Morgan Stanley | Equal Weight | $163 → $165 |
| Aug-10-26 | Reiterated | Stifel Nicolaus | $185 → $170 | |
| May-13-26 | Reiterated | Northland Securities | Outperform | $150 → $174 |
| May-13-26 | Reiterated | Morgan Stanley | Equal Weight | $151 → $163 |
| May-13-26 | Reiterated | Barclays | Overweight | $175 → $185 |
| May-13-26 | Reiterated | Evercore ISI Group | Outperform | $190 → $200 |
| May-13-26 | Reiterated | Oppenheimer | Outperform | $180 → $195 |
Camtek Ltd., operating with its subsidiaries, is dedicated to the development, manufacturing, and global distribution of advanced inspection and precision measurement tools. These critical systems serve a variety of specialized segments within the semiconductor industry, encompassing areas such as sophisticated interconnect packaging, memory components, CMOS image sensors, micro-electromechanical systems (MEMS), and radio frequency (RF) devices, among others. The company's product lineup includes key inspection and metrology platforms: Eagle-i: Provides two-dimensional (2D) inspection and measurement capabilities. Eagle-AP: Specifically designed for the advanced packaging sector, this system leverages innovative software and hardware to deliver superior 2D and 3D inspection and metrology functionalities from a single integrated platform. Golden Eagle: A dedicated panel inspection and metrology solution engineered to support fan-out wafer-level packaging applications. Camtek's market reach spans several key regions, including the Asia Pacific, the United States, and Europe, where it sells its innovative offerings. The company was founded in 1987 and its main office is situated in Migdal HaEmek, Israel.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 509 | 496 | 429 | 315 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 255 | 246 | 219 | 168 | — | — | — | — | — | |
| Gross Profit | 255 | 250 | 210 | 148 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 79 | 74 | 64 | 51 | — | — | — | — | — | |
| Research and Development | 57 | 48 | 38 | 31 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 118 | 128 | 108 | 65 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 1 | 2 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -71 | -76 | 24 | 24 | — | — | — | — | — | |
| Net Income Before Taxes | 46 | 52 | 131 | 88 | — | — | — | — | — | |
| Income Taxes | 10 | 2 | 13 | 9 | — | — | — | — | — | |
| Consolidated Net Income | 38 | 51 | 119 | 79 | — | — | — | — | — | |
| Net Income From Continuing Operations | 38 | 51 | 119 | 79 | — | — | — | — | — | |
| Net Income | 38 | 51 | 119 | 79 | — | — | — | — | — | |
| EPS (Recurring) | 0.80 | 1.11 | 2.62 | 1.76 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.80 | 1.11 | 2.62 | 1.76 | — | — | — | — | — | |
| EPS (Diluted) | 0.61 | 1.04 | 2.42 | 1.61 | — | — | — | — | — | |
| EBITDA | 29 | 64 | 143 | 95 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 177.46 | 102.26 | 33.38 | 43.09 | — | — | — | — | — | |
| Price To Sales Ratio | 10.85 | 9.86 | 8.47 | 9.91 | — | — | — | — | — | |
| Gross Margin | 50.10 | 50.40 | 48.95 | 46.98 | — | — | — | — | — | |
| Operating Margin | 23.18 | 25.81 | 25.17 | 20.63 | — | — | — | — | — | |
| Net Margin | 7.47 | 10.28 | 27.74 | 25.08 | — | — | — | — | — | |
| Shares Outstanding | 51 | 46 | 45 | 45 | — | — | — | — | — | |
| Market Capitalization | 5,521 | 4,892 | 3,635 | 3,122 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Geva-Dvash Orit | Vice President, HR | Aug 17 '26 | Sale | 175.00 | 508 | 88,900 | 5,205 | Aug 18 |
| Andorn Karni Yarl | Director | Aug 14 '26 | Sale | 164.40 | 3,176 | 522,134 | 1,343 | Aug 17 |
| Andorn Karni Yarl | Director | Aug 14 '26 | Option Exercise | 22.63 | 3,176 | 71,873 | 4,519 | Aug 17 |
| Andorn Karni Yarl | Director | Aug 13 '26 | Sale | 172.35 | 2,356 | 406,066 | 1,343 | Aug 17 |
| Langer Ram | Chief Operating Officer | Aug 13 '26 | Sale | 172.32 | 6,387 | 1,100,622 | 17,532 | Aug 17 |
| AMIT RAFI | Chief Executive Officer | Aug 13 '26 | Sale | 170.52 | 6,250 | 1,065,750 | 55,350 | Aug 17 |
| Andorn Karni Yarl | Director | Aug 13 '26 | Option Exercise | 63.51 | 880 | 55,889 | 3,699 | Aug 17 |
| Aviram Lior | Director | Aug 12 '26 | Sale | 173.87 | 3,347 | 581,943 | 12,518 | Aug 13 |
| Geva-Dvash Orit | Vice President, HR | Aug 12 '26 | Sale | 174.06 | 415 | 72,236 | 5,713 | Aug 13 |
| Eisenberg Moshe | Chief Financial Officer | Aug 12 '26 | Sale | 172.67 | 645 | 111,373 | 16,239 | Aug 13 |
| Eisenberg Moshe | Chief Financial Officer | Aug 11 '26 | Sale | 160.06 | 3,759 | 601,651 | 16,884 | Aug 13 |
| Aviram Lior | Director | Aug 11 '26 | Sale | 162.99 | 3,347 | 545,530 | 15,865 | Aug 13 |